Outcomes After Stopping Inhaled Therapies in Pediatric Cystic Fibrosis Patients on CFTR Modulators

Author

• Kaitlyn M. Gall, University of Nebraska at OmahaFollow
• Heather M. Thomas, Children's NebraskaFollow
• Angela O. Delecaris, Children's NebraskaFollow
• Ashley Deschamp, Children's Nebraska

Files

Presentation date

Summer 8-6-2026

College, Institute, or Department

Child Health Research Institute / Pediatrics

Faculty Mentor

Dr. Heather Thomas

Research Mentor

Dr. Heather Thomas

Rights

The author holds the copyright to this work and any reuse or permissions must be obtained from the author directly.

Keywords

Cystic Fibrosis, CFTR Modulator, discontinue, Pulmozyme, HTS, hypertonic saline, lung function, pulmonary exacerbation

Recommended Citation

Gall, Kaitlyn M.; Thomas, Heather M.; Delecaris, Angela O.; and Deschamp, Ashley, "Outcomes After Stopping Inhaled Therapies in Pediatric Cystic Fibrosis Patients on CFTR Modulators" (2026). Posters: 2026 Summer Undergraduate Research Program. 8.
https://digitalcommons.unmc.edu/surp2026/8